Hester Biosciences Reports Nearly Tenfold Q4 Profit Increase and 22% Revenue Growth
1 hour agoBusiness
35LENS
2 SourcesMumbai, India
TBNthebalanced.news

Hester Biosciences Reports Nearly Tenfold Q4 Profit Increase and 22% Revenue Growth

Hester Biosciences reported a significant rise in consolidated net profit for Q4 FY26, with figures increasing nearly tenfold year-on-year to around Rs 165 crore, supported by a 22% revenue growth to over Rs 1,000 crore. The poultry healthcare segment showed strong demand and operational gains, while an exceptional gain from divesting a subsidiary also contributed. Annual results reflected over 100% profit growth with moderate sales increases. Some discrepancies in reported profit figures across sources highlight variations in data presentation.

Political Bias
0%100%0%
Sentiment
75%
AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 15 May 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Political bias across 2 sources
● Left 0%● Center 100%● Right 0%

The articles focus on financial performance without political framing, presenting company-reported data and market outcomes. Both sources emphasize profit and revenue growth, with no evident political perspectives or partisan interpretations. The coverage is primarily business-oriented, reflecting corporate and market viewpoints without political commentary.

Sentiment — Positive (75/100)

The tone across the articles is positive, highlighting strong profit and revenue growth for Hester Biosciences. The language is factual and celebratory of financial gains, with emphasis on operational improvements and market demand. Minor discrepancies in figures do not affect the overall optimistic sentiment regarding the company's performance.

How 2 sources covered this story

Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.

SourceTheir headlineBiasSentiment
businessstandardHester Biosciences consolidated net profit rises 1138.76 in the March 2026 quarterCenterPositive
freepressjournalHester Biosciences Q4 Profit Jumps Nearly 10-Fold To 165 Crore, Revenue Rises 22CenterPositive

Coverage timeline

freepressjournal broke this story on 15 May, 07:23 am. Other outlets followed.

  1. 1
    freepressjournal15 May, 07:23 am
    Hester Biosciences Q4 Profit Jumps Nearly 10-Fold To 165 Crore, Revenue Rises 22
  2. 2
    businessstandard15 May, 08:53 am
    Hester Biosciences consolidated net profit rises 1138.76 in the March 2026 quarter

Lens Score breakdown

35/100
Public interest0/100
Coverage gap100%

Story is receiving appropriate media attention relative to public interest.

Who's involved

Institutions and figures named across source coverage.

Corporate
Hester Biosciences LtdHester BiosciencesTexas Lifescience Private LimitedHindustan ZincBajaj GlobalVinayak Polycon InternationalMphasis LtdUno Minda Ltd

Story context

Category
Business
Location
Mumbai, India
Sources analysed
2
Last analysed
15 May 2026
Key entities
CroreIndian rupeeHester BiosciencesNet incomeHealth carePoultryFiscal yearRevenueMumbaiProfit marginDivestmentSubsidiary